You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peripheral blood T cell subpopulations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T- and B-Cell Subpopulations in Membranous Nephropathy

Recruiting
  • Membranous Nephropathy
  • +2 more
    • Istanbul, Turkey
      Istanbul University
    May 31, 2023

    Minimal Residual Disease in Peripheral T-cell Lymphoma

    Active, not recruiting
    • Peripheral T Cell Lymphoma
    • Tumor biopsy
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Dec 19, 2022

    Hepatocellular Carcinoma Trial in Yichang (Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Sep 1, 2023

    CX3CR1+T Cell Predict Immunotherapy Efficacy

    Recruiting
    • Non-small Cell Lung Cancer
    • PD-1 inhibitor based immunotherapy
    • Changsha, Hunan, China
    • +1 more
    Sep 19, 2023

    Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma Trial in Xiamen (Chidamide combined

    Recruiting
    • Peripheral T Cell Lymphoma
    • +2 more
    • Chidamide combined with Duvillisib
    • Xiamen, Fujian, China
      The First Affiliated Hosptial of Xiamen University
    Nov 28, 2023

    Circulating Tumor DNA Sequencing in Peripheral T-cell Lymphomas

    Not yet recruiting
    • Peripheral T Cell Lymphoma
    • circulating tumoral DNA detection
    • Rouen, France
      Centre Henri Becquerel
    Oct 13, 2023

    Peripheral Blood Neoantigen Specific T Cells Predict Efficacy of

    Recruiting
    • Esophageal Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Cancer hospital Fudan University
      Nov 30, 2022

      Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

      Recruiting
      • Newly Diagnosed Peripheral T-cell Lymphoma
      • Duvelisib, Chidamide
      • Wuhan, Hubei, China
        Union Hospital, Tongji Medical College, Huazhong University of S
      Jul 27, 2023

      Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Trial (GFH009)

      Not yet recruiting
      • Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
      • (no location specified)
      Jun 28, 2023

      Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma Trial in Changchun (Rituximab,

      Recruiting
      • Peripheral T-Cell Lymphoma, Not Otherwise Specified
      • Angioimmunoblastic T-cell Lymphoma
      • Changchun, Jilin, China
        The First Bethune Hospital of Jilin University
      Apr 7, 2023

      Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

      Not yet recruiting
      • Graft Vs Host Disease
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 18, 2023

      NSCLC Trial in Yichang (Sindillimab)

      Completed
      • Non-small Cell Lung Cancer
      • Yichang, Hubei, China
        Department of Medical Oncology, Central Hospital of Yichang City
      Mar 29, 2023

      End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet

      Completed
      • End Stage Renal Disease
      • Rejection of Renal Transplant
      • Tacrolimus
      • Tacrolimus Extended Release Oral Tablet [Envarsus]
      • Chicago, Illinois
        Northwestern University
      Jan 12, 2023

      Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)

      Recruiting
      • Peripheral T Cell Lymphoma
      • Epigenetic Repression
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jul 14, 2023

      Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)

      Not yet recruiting
      • Peripheral T Cell Lymphoma
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Jul 18, 2023

      Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

      Completed
      Has Results
      • Anaplastic Large Cell Lymphoma, ALK-Negative
      • +9 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +8 more
      • Duarte, California
      • +7 more
      Nov 4, 2022

      Peripheral T Cell Lymphoma Trial in Shandong, Shanghai, Sichuan (84-gene penal)

      Not yet recruiting
      • Peripheral T Cell Lymphoma
      • 84-gene penal
      • Shandong, China
      • +2 more
      Jul 6, 2023

      Peripheral T Cell Lymphoma Trial in Zhengzhou (SHR0302)

      Not yet recruiting
      • Peripheral T Cell Lymphoma
      • Zhengzhou, Henan, China
        Henan cancer hospital
      Jun 2, 2023

      Peripheral T-cell Lymphoma Trial (Linperlisib in combination with CHOP)

      Not yet recruiting
      • Peripheral T-cell Lymphoma
      • Linperlisib in combination with CHOP
      • (no location specified)
      Jul 10, 2023

      Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)

      Not yet recruiting
      • Peripheral T Cell Lymphoma
      • CAR-T Therapy
      • Hefei, Anhui, China
      • +7 more
      Jul 31, 2023

      Peripheral T Cell Lymphoma Trial in Duarte, Aurora, Philadelphia (Nivolumab and EPOCH)

      Active, not recruiting
      • Peripheral T Cell Lymphoma
      • Nivolumab and EPOCH
      • Duarte, California
      • +2 more
      Jan 6, 2023

      Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

      Not yet recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +5 more
      • (no location specified)
      Nov 2, 2023

      Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

      Completed
      Has Results
      • Leukemia
      • +2 more
      • CliniMACS Fractionation system (Arm A)
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 12, 2022

      Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype Trial in Guangzhou (Chidamide combined with CHOP,

      Recruiting
      • Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
      • Guangzhou, Guangdong, China
        Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
      Oct 7, 2022

      Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

      Recruiting
      • Newly Diagnosed Peripheral T-cell Lymphoma
      • Nanjing, Jiangsu, China
        Hematological Department, People's Hospital of Jiangsu Province
      Jun 1, 2023